Latest news
As GLP-1 use scales, dermatology is becoming part of obesity care
A multinational survey presented at EADV 2026 found more self-reported hair, scalp and nail problems among people using GLP-1 receptor agonists than among metabolically similar non-users.
Diarrhoeal Disease Progress Is Real. The Inequality Is Still Brutal.
MenB Vaccination Moves From Baby Schedule to Student Outbreak Control
Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice
Sanofi’s Tzield moves type 1 diabetes into disease modification, but access may decide who benefits
WHO is preparing to ration the obesity drug revolution before it becomes another access disaster
CAR-T Starts Moving From Factory Medicine to In-Patient Engineering
AML’s Frontline Future Starts With Finding the Mutation Fast
FSHD Gets a Stronger Biological Signal
ALS Immunotherapy Moves Into the Extension Phase
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.